CNR2 and neoplasm: Similar to Cnr2-deficient T cells, Cnr2 knockdown OT-I T cells significantly inhibited the growth of B16-OVA tumors and improved survival of tumor-bearing mice compared to the OT-I T cells transduced with LacZ shRNA (Fig. 5f).